Up, page-7

Seen it all too often
Nothing has changed , we are talking about data from a study done 5-7 years ago? ... I can't be bothered looking it up.
Nobody has wanted 1102 since teva handed it back 6-7 years ago
So what has changed
Somebody needs to spend in excess of 200 million to get 1102 through to registration that's if it passes trials without side affects and toxicity problems which seems to keep popping up on the antisense platform.
Give it a day or 2 and it will turn back into the illiquid stock /investor disaster that it has been historically. Just feel for any new suckers.
It will stay this way until either a genuine partner comes a long which given the history of deal making from this company is unlikely seeing as everyone hands back whatever Anp has.
...or Diamond resigns .
Good luck with that.